EBP After Midterm Material

0.0(0)
studied byStudied by 16 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/125

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

126 Terms

1
New cards

Diagnosis

  • A process that…​

    • Labels patients​

    • Classifies a problem​

    • Determines prognosis​

    • Determines intervention

2
New cards

Purpose of a Diagnosis

  • Focus the examination on a particular body region or symptom​

  • Identify potential problems requiring referral to a physician or other specialist​

  • Assist in the classification process​

3
New cards

Test Threshold

“The probability below which a diagnostic test will not be ordered or performed because the possibility of the diagnosis is so remote”

4
New cards

Treatment Threshold

  • “The probability above which a diagnostic test will not be ordered or performed because the possibility of the diagnosis is so great that immediate treatment is indicated.”​

  • meaning Probability is so high, I probably don’t need a diagnostic test bc I am very likely this happens  

5
New cards

Sensitivity

  • Ability of the test to correctly identify     (+ test result) in someone with the disorder​

6
New cards

equation for sensitivity

patients with the disorder who test positive/ all patients with the disorder

true positive / (true positive +false negative)

7
New cards

Specificity

  • Ability of the test to correctly identify      (- test result) in someone without the disorder​

8
New cards

equation for Specificity

patients without the disorder who test negative / all patients without the disorder

true negative / (false positive + true negative)

9
New cards

Positive Predictive Value

 

  • Ability of the test to correctly determine the % of people with the disorder from all of the people with positive test results

10
New cards

equation for Positive predictive Value

Patients with the disorder who test positive​

over

All patients who test positive

a/ a+b

11
New cards

Negative Predictive Value

  • Ability of the test to correctly determine the % of people without the disorder from all of the people with a negative test result​

  • How many people who tested negative truly don’t have the condition ​

12
New cards

equation for Negative predictive Value

Patients without the disorder who test negative​ / All patients who test negative

true negative / (false negative + true negative)

13
New cards

Positive Likelihood Ratio

  • The likelihood that a positive test result was observed in a person with the disorder v. in a person without the disorder of interest​

  • Ratio of True + : false + ​

  • Range from 0- infinity​

  • Likely over 1 ​

  • Want it to be high

14
New cards

equation for Positive Likelihood Ratio

Sensitivity / 1 - Specificity​

15
New cards

Negative Likelihood Ratio

  • The likelihood that a negative test result is observed in a person with the disorder v. in a person without the disorder of interest​

  • Ratio of False - : True –

16
New cards

equation for negative likelihood ratio

1 - Sensitivity​

      over

 Specificity

17
New cards

what does it mean if LR+ > 10 or LR - < 0.10​

large and conclusive change

18
New cards

what does it mean if LR+ = 5-10 or LR- = 0.10-0.20​

moderate change

19
New cards

what does it mean if LR+ = 2-5 or LR- = 0.20-0.50​

small, but sometimes important change

20
New cards

what does it mean if LR+ = 1-2 or LR- = 0.50-1.0

Negligible change in pre-test probability​

21
New cards

How do you determine pre- test probability?

  • Prevalence (%)​

    • Could get from history, collect from subjective ​

22
New cards

How do you determine pre-test odds?

  • What you think the odds are that the patient has the disorder before you conduct the diagnostic test​

  • = pretest probability/ 1-pretest probablity​

23
New cards

How do you determine post-test odds?

  • What you think the odds are that the patient has the disorder after you conduct the diagnostic test​

  • = pretest odds x LR+/-​

24
New cards

How do you determine post-test probability?

  • Probability of the disorder once the test results are obtained​

  • = Posttest odds/ posttest odds + 1

25
New cards

p-value

 the probability that the result (e.g., correlation coefficient, Sn, Sp, PPV, PNV, LR+, LR-) occurred due to chance

26
New cards

95% confidence interval

 the range of values within which the true value is estimated to lie within a 95% probability

27
New cards

Considerations and clinical tests/ measures for diagnostic criteria

  • Reliability/Validity

  • Minimal Detectable Change (MDC)

  • Sn, Sp, LR, PV ?

28
New cards

Additional Considerations for diagnostic testing credibility

  • Is there a detailed description of the:

    • Clinical Setting

    • Inclusion criteria

    • Exclusion criteria

    • Protocol for test(s)

29
New cards

Prognosis

  • A process that tells us…

    • Which outcomes could happen

    • The likelihood that outcomes will happen

    • The timeframe for outcome development

    • Develop POC and set goals

30
New cards

prognostic indicator

may predict any type of event or outcome

31
New cards

risk factor

predicts adverse events or outcomes

32
New cards

Case control study

  • Retrospective comparison of two groups

  • 1 group w/ disorder or outcome, 1 group w/o disorder or outcome

  • Look at proportion of each group who had the risk factor or prognostic indicator of interest

33
New cards

cohort study

  • Prospective comparison of two or more groups before they have the disorder or outcome

  • Monitor the groups to see who develops the disorder or outcome and identify what characteristics they have

34
New cards

predictive model

  • Can use retrospective or prospective data

  • Regression model determines which relevant factors predict the outcome of interest

35
New cards

survival rates

What is the rate of outcome development over time ​

36
New cards

relative risk

  • Ratio of risk for developing the adverse outcome in patients with the risk factor versus patients without the risk factor

  • With people who have the factor, which of them develop the outcome​

  • Generally depends on being able to determine incidence of the outcome​

    • Best for prospective studies

37
New cards

odds ratio

  • The likelihood that an individual with the prognostic or risk factor will develop the outcome of interest

  • Seen in prospective and retrospective, better for prospective​

  • Likelihood of the event occurring in a specific group ​

    • Proportion of people who do have it to people who don't​

38
New cards

equation for Odds ratio

(a/b) / (c/d)

<p>(a/b) / (c/d)</p>
39
New cards

equation for relative risk

(a/a+b)/ (c/c+d)

<p>(a/a+b)/ (c/c+d)</p>
40
New cards

what does a RR >1 mean?

increased risk of adverse outcome

41
New cards

what does a RR of <1 mean?

decreased risk of an adverse outcome

42
New cards

what does an OR >1 mean if the outcome is negative?

the odds are in favor of an adverse outcome

the problem will develop

43
New cards

what does an OR >1 mean if the outcome is positive?

the odds are in favor of a positive outcome

44
New cards

what does an OR <1 mean if the outcome is negative?

the odds are against an adverse outcome

the prognostic factor is protective against the problem

45
New cards

what does an OR <1 mean if the outcome is positive?

the odds are against a positive outcome

the prognostic factor is harmful

46
New cards

What should be considered about a regression analysis?

the more factors/ variables there are, the more people you need to have to power it

you should have 20 people per factor

47
New cards

what does an OR of 1 mean?

represents a 50:50 chance of increasing or decreasing the odds that the outcome will occur

48
New cards

what does a RR of 1 mean?

represents a 50:50 chance increasing or decreasing the risk that the outcome will occur

49
New cards

issues related to experimental designs

 best for controlling bias, but excessive control may overshadow clinical relevance

50
New cards

issues with quasi experimental designs

 more vulnerable to bias, but may be more clinically relevant

51
New cards

issues with non-experimental designs

most vulnerable to bias, but may be most clinically relevant

52
New cards

what is the outcome under ideal conditions?

efficacy

53
New cards

what is the outcome in the clinical scenario?

effectiveness

54
New cards

effect size

  • a statistical expression of the size of the difference between sample means”

    • Effect from pre to post / independent of sample size

55
New cards

equation for absolute effect size

mean score (experimental) - mean score (control)

56
New cards

equation for standardized effect size

mean score (experimental) - mean score (control) / pooled standard deviation

57
New cards

treat to effect size

not having enough power or big enough sample

58
New cards

weakness to effect size

doesn’t consider the roles of bias  and doesn’t consider if it is normally distributed or not (skewed data can lead to large effect sizes)

59
New cards

Cohen’s D

most common equation to find pooled standard deviation

60
New cards

what is considered a large effect size / big effect?

0.8

61
New cards

what is considered a big enough effect from treatment that we can see it with the naked eye?

0.5-0.8

62
New cards

what is considered an effect size where the treatment effect is small enough that we cannot see it with the naked eye?

0.2-0.49

63
New cards

what is considered no treatment effect using effect size?

<0.2

64
New cards

Minimally clinically important difference

  • The minimal level of change REQUIRED in response to an intervention before the outcome would be considered worthwhile

  • Should at least exceed the standard error of measurement (SEM) for the outcome of interest

65
New cards

absolute benefit increase

  • There was x % difference in positive outcomes between experimental and control groups

  • Percent of people that would benefit from the treatment

    •  % therapy group w/ outcome - % control group w/ outcome

66
New cards

equation for Number needed to treat

1/ ABI

67
New cards

Number needed to treat

for every “x” number of individuals, 1 will have the positive outcome

68
New cards

relative benefit increase

  • Absolute difference in positive outcome relative to everyone with the outcome

  • Those who receive the treatment improve by x% relative to those who didn’t receive the treatment

  • the more people in the control that get better, this value would be lower

69
New cards

equation for relative benefit increase

(% therapy group w/ outcome - % controls w/ outcome) /

(% of controls w/ outcome)

70
New cards

equation for relative risk reduction

(% controls group w/ outcome - % therapy group w/ outcome) /

(% of controls w/ outcome)

71
New cards

equation for absolute risk reduction

% controls w/ problem - % therapy group w/ problem

72
New cards

Absolute risk reduction

By how much does the intervention reduce the risk of an unwanted “event” (i.e., injury)?

73
New cards

outcome measures

measures taken to asses the impact of a disease or disorder ont he patient

74
New cards

test retest

reproducibility (stability) of a score  when a measure is repeated under the same  conditions at the same point in time

75
New cards

internal consistency

relationship between items in a  questionnaire

(going to look at all the items and if they are related to each other and the change in the overall  measure)

76
New cards

tests used to determine test-retest

ICC and Kappa

77
New cards

Tests used to determine internal consistency

Chronbach’s alpha

78
New cards

what is an appropriate range for chronbach’s alpha

0.7-0.9

79
New cards

Why do we not want a range of 0.9-1.0 for a chronbach’s alpha value?

the questions the measure is asking may be redundant, so we may need to ask different things

80
New cards

what is an appropriate ICC value?

>0.75

81
New cards

What is an appropriate kappa value?

>0.51

82
New cards

what do regression equations determine?

Predictive validity- if they fall below a score, are they more likely to have a good or poor outcome with therapy

83
New cards

Sources of measurement error

  • Instrument

  • Person collecting measure

  • Environment

  • Patient

84
New cards

Standard Error of Measurement

error at a single point in time

85
New cards

equation for standardized response mean

 mean of change scores / standard deviation  of change scores

86
New cards

"good” standard response mean value

 > 1.0

87
New cards

equation to find effect size

 mean of change scores / standard deviation of initial scores

88
New cards

“large” effect size value

> 0.8

89
New cards

Clinical Prediction Rule

  • Cluster of s/s to provide meaningful info or predictions of an outcome of interest that are:

    • Systematically derived

    • Statistically tested

90
New cards

what does the derivation step of CPR do?

identifies of factors with predictive power

91
New cards

what level of evidence is derivation

4

92
New cards

what does the narrow validation step of CPR do

applies the rule in a similar clinical setting and population as the derivation process

93
New cards

what does the Broad validation step of CPR do

applies the rule to multiple clinical settings with varying prevalence and outcomes of the condition

94
New cards

what does the impact analysis step of CPR do

identifies that a rule changes physician behavior and improves patient outcomes / reduces costs

95
New cards

what level of evidence is narrow validation?

3

96
New cards

What level of evidence is broad validation?

2

97
New cards

What level of evidence is impact analysis?

1

98
New cards

Clinical prediction Guidelines

  • Statements to assist practitioner and patient decisions in specific circumstances

    • Systematically developed

      • Have some component of a systematic review associated w them

99
New cards

what do CPG’s reflect?

  • Current best evidence

  • Expert clinical judgment

  • Patient opinion/perspective

    • Should be a good representation of evidence based practice

100
New cards

Who were CPG’s developed by?

  • Government agencies

  • Professional societies